Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention

Neurological Surgery

Volumn 40, Issue 5, 2012, Pages 399-406

  Haraguchi, Kenichi ^a   Miyachi, Shigeru ^a   Izumi, Takashi ^a   Matsubara, Noriaki ^a   Naito, Takehiro ^a   Asai, Takumi ^a   Yamanouchi, Takashi ^a   Wakabayashi, Toshihiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiplatelet agent; Low responder; Neurointervention; Resistance

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL;

ANEURYSM; ARTICLE; ARTIFICIAL EMBOLISM; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DRUG EFFECT; DRUG RESPONSE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; NEUROSURGERY; POINT OF CARE TESTING; THROMBOCYTE FUNCTION; THROMBOEMBOLISM;

ADULT; AGED; ASPIRIN; DRUG RESISTANCE; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; TETRAZOLES; THROMBOEMBOLISM; TICLOPIDINE;

EID: 84861726912     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Accumetrics Inc., http://www.accumetrics.com/press-releases/2011may17/
2. Accumetrics Inc., VerifyNow® SYSTEM [package insert], 2009
3. Alván G, Bechtel P, Iselius L, Gundert-Remy U : Hydroxylation polymorphisms of debrisoqulne and mephenytoin in European populations : Eur J Clin Pharmacol 39 : 533-537, 1990
4. Bennett D, Yan B, Macgregor L, Eccleston D, Davis SM : A pilot study of resistance to aspirin in stroke patients. J Clin Neurosci 15 : 1204-1209, 2008
5. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ten Berg JM, Hackeng CM : High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events. J Thromb Haemost 8 : 2140-2148, 2010
6. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA, Rensing BJ, Suttorp MJ, Hackeng CM, ten Berg JM : Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 303 : 754-762, 2010
7. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Harmsze AM, Hackeng CM, ten Berg JM : High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention. Heart 97 : 983-990, 2011
8. Chariot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Køber L, Torp-Pedersen C, Gislason GH : Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction : nationwide propensity score matched study. BMJ 342 : d2690, 2011
9. Crescente M, Di Castelnuovo A, Iacoviello L, de Gaetano G, Cerletti C : PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients : a meta-analysis of 19 studies comprising 3,003 patients. Thromb Haemost 99 : 1129-1131, 2008 (Pubitemid 351810502)
10. de Miguel Castro A, Cuellas Ramón C, Diego Nieto A, Samaniego Lampón B, Alonso Rodríguez D, Fernández Vázquez F, Alonso Orcajo N, Carbonell de Blas R, Pascual Vicente C, Pérez de Prado A : Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome. Rev Esp Cardiol 62 : 126-135, 2009
11. Dichiara J, Bilden KP, Tantry US, Chaganti SK, Kreutz RP, Gesheff TB, Kreutz Y, Gurbel PA : Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. Platelets 18 : 414-423, 2007 (Pubitemid 47347051)
12. Feher G, Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Papp E, Szapary L, Kesmarky G, Toth K : Clinical importance of aspirin and clopidogrel resistance. World J Cardiol 2 : 171-186, 2010
13. Gasparyan AY, Watson T, Lip G Y : The role of aspirin in cardiovascular prevention : implications of aspirin resistance. J Am Coll Cardiol 51 : 1829-1843, 2008 (Pubitemid 351615246)
14. Godino C, Mendolicchio L, Figini F, Latib A, Sharp AS, Cosgrave J, Calori G, Cera M, Chieffo A, Castelli A, Maseri A, Ruggeri ZM, Colombo A : Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy? Thromb J 7 : 4, 2009
15. Goldstein JA, Ishizaki T, Chiba K, de Morais SM, Bell D, Krahn PM, Evans DA : Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics 7 : 59-64, 1997 (Pubitemid 27153320)
16. Hwang SJ, Jeong YH, Kim IS, Park KS, Kang MK, Koh JS, Park JR, Park Y, Koh EH, Kwak CH, Hwang JY, Kim S : Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 3 : 450-459, 2010
17. Jakubowski JA, Payne CD, Li YG, Brandt JT, Small DS, Farid NA, Salazar DE, Winters KJ : The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thromb Haemost 99 : 409-415, 2008 (Pubitemid 351230973)
18. Jeon SB, Song HS, Kim BJ, Kim HJ, Kang DW, Kim JS, Kwon SU : Biochemical aspirin resistance and recurrent lesions in patients with acute ischemic stroke. Eur Neurol 64 : 51-57, 2010
19. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM : A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 180 : 713-718, 2009
20. Kang HS, Kwon BJ, Kim JE, Han MH : Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms : clinical implications. AJNR Am J Neuroradiol 31 : 1206-1210, 2010
21. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR : Aspirin "resistance" and risk of cardiovascular morbidity : systematic review and meta-analysis. BMJ 336 : 195-198, 2008 (Pubitemid 351212675)
22. Kubota T, Chiba K, Ishizaki T : Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population. Clin Pharmacol Ther 60 : 661-666, 1996 (Pubitemid 27025913)
23. Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME : Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test : a single-center experience. AJNR Am J Neuroradiol 29 : 1389-1394, 2008
24. Malinin A, Pokov A, Swaim L, Kotob M, Serebruany V : Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel. Methods Find Exp Clin Pharmacol 28 : 315-322, 2006 (Pubitemid 44047198)
25. Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V : Monitoring platelet inhibition after clopidogrel with the VerifyNowP2Y12(R) rapid analyzer : the VERIfy Thrombosis risk Assessment (VERITAS) study. Thromb Res 119 : 277-284, 2007 (Pubitemid 44918092)
26. Medical Tribune 43 : 24, 2010
27. Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R : Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost 104 : 287-292, 2010
28. Patrono C, García Rodríguez LA, Landolfi R, Baigent C : Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 : 2373-2383, 2005 (Pubitemid 41713749)
29. Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS. Schatz RA, Teirstein PS : Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29 : 992-1000, 2008 (Pubitemid 351844676)
30. Price MJ : Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 119 : 2625-2632, 2009
31. Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ; GRAVITAS Investigators : Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention : the GRAVITAS randomized trial. JAMA 305 : 1097-1105, 2011
32. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B : ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 : e1-e121, 2006 (Pubitemid 43005195)
33. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV : Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events : a systematic review and meta-analysis. Arch Intern Med 167 : 1593-1599, 2007 (Pubitemid 47280339)
34. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV : Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting : a systematic review and meta-analysis. Am Heart J 154 : 221-231, 2007 (Pubitemid 47069129)
35. Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF : Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events - a meta-analysis. Int J Cardiol 128 : 166-171, 2008
36. Tanigawa T, Nakata T, Ito M, Nishikawa M, The McLORDD Study Group : Improvement of clopidogrel hypo-responsiveness by cilostazol addition to the dual antiplatelet therapy in PCI patients carrying CYP2C19 gene polymorphism. Circulation 122 (21-MeetingAbstracts) : 14257, 2010
37. Tran HA, Anand SS, Hankey GJ, Eikelboom JW : Aspirin resistance. Thromb Res 120 : 337-346, 2007 (Pubitemid 46879910)
38. von Beckerath N, Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, Schömig A : A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J 28: 1814-1819, 2007 (Pubitemid 47236637)